Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-056364

Chief Development Officer sold 494 shares at $16.54 ($8,171)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Curley Joanne Chief Development Officer 2022-11-09 Sale −494 $16.54 $8,171 27,315 D
Open-market sales · 494 sh · avg $16.54 · $8,171
Loading xslF345X03/doc4.xml…